NYLIM
BSX icon

New York Life Investment Management’s Boston Scientific BSX Stock Holding History

New York Life Investment Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.45M Buy
221,348
+902
+0.4% +$49K 0.07% 238
2026
Q1 		$13.8M Buy
220,446
+5,780
+3% +$462K 0.12% 154
2025
Q4 		$20.5M Buy
214,666
+13,458
+7% +$1.32M 0.18% 111
2025
Q3 		$19.6M Sell
201,208
-4,649
-2% -$481K 0.17% 115
2025
Q2 		$22.1M Buy
205,857
+3,790
+2% +$383K 0.21% 94
2025
Q1 		$20.4M Sell
202,067
-1,227
-0.6% -$124K 0.21% 102
2024
Q4 		$18.2M Buy
203,294
+2,488
+1% +$219K 0.18% 108
2024
Q3 		$16.8M Sell
200,806
-6,082
-3% -$479K 0.16% 122
2024
Q2 		$15.9M Buy
206,888
+1,017
+0.5% +$74.4K 0.16% 128
2024
Q1 		$14.1M Sell
205,871
-7,232
-3% -$465K 0.14% 140
2023
Q4 		$12.3M Sell
213,103
-1,207
-0.6% -$64.4K 0.13% 150
2023
Q3 		$11.3M Buy
214,310
+6,039
+3% +$317K 0.12% 151
2023
Q2 		$11.3M Buy
208,271
+2,020
+1% +$106K 0.12% 157
2023
Q1 		$10.3M Buy
206,251
+872
+0.4% +$41.1K 0.11% 179
2022
Q4 		$9.5M Sell
205,379
-527
-0.3% -$22.8K 0.11% 199
2022
Q3 		$7.97M Buy
205,906
+1,414
+0.7% +$56.7K 0.1% 221
2022
Q2 		$7.62M Buy
+204,492
New +$8.32M 0.09% 238

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

New York Life Investment Management's BSX Position: Q2 2026 in Review

New York Life Investment Management increased its Boston Scientific (BSX) stake by 0.41% in Q2 2026, buying an estimated $49K and bringing the position to 221,348 shares worth $9.45M. The position accounts for 0.07% of the portfolio, ranked #238.

New York Life Investment Management first reported a position in BSX in Q2 2022 and has held it in 17 quarters since. The position peaked at $22.1M in Q2 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • New York Life Investment Management held 221,348 shares of Boston Scientific worth $9.45M as of Q2 2026.
  • New York Life Investment Management bought 902 Boston Scientific shares in Q2 2026, an estimated $49K.
  • Boston Scientific made up 0.07% of New York Life Investment Management's portfolio in Q2 2026, its #238 holding.
  • New York Life Investment Management first reported a position in Boston Scientific in Q2 2022 and has held it in 17 quarters since.
  • New York Life Investment Management's Boston Scientific position peaked at $22.1M in Q2 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.